Zhong Lun Law Firm has recruited corporate lawyer Tom Fairley as its first Western partner in its London office, which opened last year.



Fairley has joined the Chinese firm from British firm Taylor Vinters. Prior to his tenure at Taylor Vinters, he has also practised with Norton Rose in Shanghai in addition to Linklaters in Shanghai, Hong Kong and London. His expertise areas include cross-border mergers and acquisitions, disposals and joint ventures, acting for both Chinese and multinational clients.



"We are very pleased to have someone of Tom’s unique qualifications join our team in London. Working together with our existing team of senior Chinese-trained, English-qualified lawyers in our London office, Tom will bring an important complementary set of skills which will assist us as we expand upon our existing cooperation relationships with top independent law firms in London on the full range of China-related projects in the UK and Europe,” said Xue Haibin, managing partner of Zhong Lun’s London office, in a press release.



“Now that Chinese enterprises are expanding into overseas markets, Zhong Lun needs high-calibre lawyers who speak the international language of commerce in both English and Mandarin to assist with projects going in both directions,” added Robert Lewis, international managing partner of Zhong Lun.



Fairley has worked in China for more than 10 years, and is fluent in Mandarin. He has a masters in Chinese from the Cambridge University, and has attended the Nottingham law school.



“This is a very exciting move for me. I decided to join a Chinese firm in the heart of the City because I really respect the strategic vision of the Zhong Lun partners to build a top-tier world class Chinese law firm,” said Fairley.



Liu Zhen is China senior journalist at ALB.

Related Articles

中伦、君合等牵头香港第二宗18C章上市项目(ZH/EN)

智能汽车芯片公司黑芝麻智能在香港联交所主板成功上市。发行人方面,中伦律师事务所担任中国律师,高伟绅律师事务所担任香港及美国律师,高盖茨律师事务所就美国出口管制法律提供意见;保荐人方面,君合律师事务所担任中国律师,美国威尔逊律师事务所担任香港及美国律师。

深度 | 香港打造“离家更近”的纳斯达克,推动科创中心战略(ZH/EN)

by Charlie Wu 吴卓言 |

继2018年推出18A章未盈利生物医药企业上市规则后,2023年,香港联交所18C章针对未盈利特专科技公司的上市规则落地,通过放宽上市门槛、强调研发投入、引入第三方投资规定等方式提供更灵活的上市支持。吸引更多优质科创企业落地的同时,上述举措也不断推动香港实现打造全球科创中心的战略。

中伦迎四位专家加盟上海、北京及成都办公室(ZH/EN)

by Charlie Wu 吴卓言 |

中伦律师事务所近日迎来四位专家以合伙人身份加盟,柯爱艳、李雄律师将加入其上海办公室,张海军律师将加入北京办公室,张晓琴律师则将加盟成都办公室。